 Bharat Petroleum Corporation Ltd consolidated Q2FY26 net profit slips QoQ to Rs. 6191.49 crores
Bharat Petroleum Corporation Ltd consolidated Q2FY26 net profit slips QoQ to Rs. 6191.49 crores Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati
Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati Firstsource and Monash University Sign Strategic MoU
Firstsource and Monash University Sign Strategic MoU Deep Diamond India Limited declares interim dividend of Rs. 0.10
Deep Diamond India Limited declares interim dividend of Rs. 0.10 Steelcast Ltd declares 2nd interim dividend of Rs. 0.36
Steelcast Ltd declares 2nd interim dividend of Rs. 0.36 
              SBI Funds Management Pvt Ltd has announced that SBI Mutual Fund, through various schemes has sold 30000 shares of Dr. Lal PathLabs Ltd, representing 0.0360% of the paid up share capital of the company on March 14, 2018.
The final holding of SBI Mutual Fund, through various schemes was 30,45,089 equity shares which is 3.6541% of the paid up share capital of the company.
Prior to the sale, the fund had 3,075,089 equity shares or 3.6901% stake in the company.
Shares of Dr. Lal PathLabs Ltd was last trading in BSE at Rs.898 as compared to the previous close of Rs. 888.75. The total number of shares traded during the day was 2020 in over 115 trades.
The stock hit an intraday high of Rs. 901.1 and intraday low of 874. The net turnover during the day was Rs. 1791331.